Accueil > Conférences / Présentations > The impact of universal test and treat on HIV incidence in a rural South (...)

AIDS 2016

The impact of universal test and treat on HIV incidence in a rural South African population : ANRS 12249 TasP trial, 2012-2016

mercredi 17 août 2016
Mis à jour le lundi 22 août 2016

The main results of the ANRS 12249 Treatment as Prevention trail were presented at the 21st International AIDS Conference (AIDS 2016) in Durban in July 2016.

Authors

C. Iwuji, J. Orne-Gliemann, E. Balestre, J. Larmarange, R. Thiebaut, F. Tanser, N. Okesola, T. Makowa, J. Dreyer, K. Herbst, N. Mc Grath, T. Barnighausen, S. Boyer, T. De Oliveira, C. Rekacewicz, B. Bazin, M.-L. Newell, D. Pillay, F. Dabis, for the ANRS 12249 TasP Study Group

Abstract

Background : The population impact of universal test and treat (UTT) on HIV transmission has not yet been evaluated.

Methods : A cluster-randomized trial was implemented in 2x11 rural communities in KwaZulu-Natal, South Africa. All residents ≥16 years were offered rapid HIV testing and provided dried blood spots (DBS) during 6-monthly home-based survey rounds. HIV-positive participants were referred to cluster-based trial clinics to receive ART regardless of CD4 count (intervention arm) or according to national guidelines (control arm). Standard of care ART was also available in the Department of Health clinics. HIV incidence was estimated on repeat DBS using cluster-adjusted Poisson regression.

Results : Between 03/2012 and 04/2016, 13,239 and 14,916 individuals (63% women, median age 30 years) were registered in the intervention and control arms. Contact frequency per round among registered individuals ranged from 64% to 83%, HIV ascertainment from 74% to 85%. Baseline HIV prevalence was 29.4%(95%CI 28.8-30.0), with 7,578 individuals identified as HIV-positive. 1,513(36%) of 4,172 HIV-positive individuals not previously in care linked to trial clinics within 6 months of referral. ART initiation in trial clinics at 3 months was 90.9%(576/634) and 52.3%(332/635) in the intervention and control arms ; viral suppression (< 400 copies/mL) 12 months after ART initiation was 94.9%(300/316) and 94.2%(194/206), respectively. Overall ART coverage at entry was 31% and 36% in the intervention and control arms, reaching 41% in both arms by closing date. Repeat DBS tests were available for 13,693 individuals HIV-negative at baseline, yielding 461 seroconversions in 20,833 person-years (PY). HIV incidence was 2.16 per 100 PY (1.88-2.45) in the intervention arm and 2.26 (1.98-2.54) in the control arm (adjusted relative risk : 0.95 [0.82-1.10]). Severe adverse events rates were 3.4%(45/1,323) and 3.5%(57/1,604) in the intervention and control arms. Follow-up will be completed by 06/2016.

Conclusions : Our trial shows high acceptance of home-based HIV testing and high levels of viral suppression among individuals on ART. However overall linkage to care remains poor. No reduction in HIV incidence was demonstrated. Several factors are being investigated, including determinants of poor linkage, change in national ART guidelines, migration and geography of sexual networks.

(Funded by ANRS, GiZ and 3ie ; Clinical Trials registration NCT00332878)

Video

Medias

Slides

Reference

Iwuji Collins, Orne-Gliemann Joanna, Balestre Eric, Larmarange Joseph, Thiébaut Rodolphe, Tanser Frank, Okesola Nonhlanhla, Makowa Thembisa, Dreyer Jaco, Herbst Kobus, McGrath Nuala, Bärnighausen Till, Boyer Sylvie, de Oliveira Tulio, Rekacewicz Claire, Bazin Brigitte, Newell Marie-Louise, Pillay Deenan, Dabis François et ANRS 12249 TasP Study Group (2016) « The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012-2016 » (communication orale n°FRAC0105LB), présenté à 21st International AIDS Conference (AIDS 2016), Durban. http://programme.aids2016.org/Abstract/Abstract/10537.

Voir en ligne : AIDS 2016 programme

Répondre à cet article

modération a priori

Attention, votre message n’apparaîtra qu’après avoir été relu et approuvé.

Qui êtes-vous ?

Pour afficher votre trombine avec votre message, enregistrez-la d’abord sur gravatar.com (gratuit et indolore) et n’oubliez pas d’indiquer votre adresse e-mail ici.

Ajoutez votre commentaire ici
  • Ce formulaire accepte les raccourcis SPIP [->url] {{gras}} {italique} <quote> <code> et le code HTML <q> <del> <ins>. Pour créer des paragraphes, laissez simplement des lignes vides.

Ajouter un document

Retour haut de page
Site réalisé avec SPIP | Plan du site | Contact | Crédits | Mentions Légales | Suivre la vie du site RSS 2.0
Habillage visuel © Larma par Joseph Larmarange sous Licence Creative Commons Attribution 2.5 License